Literature DB >> 8751087

Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

R Maldonado1, O Valverde, C Garbay, B P Roques.   

Abstract

The aim of this study was to evaluate the role played in the behavioral expression of morphine withdrawal syndrome by protein kinases in the locus coeruleus and the periaqueductal gray matter. Two different families of specific protein kinases have been investigated: serine/threonine and tyrosine kinases. Rats were implanted with cannulas into both the lateral ventricle and the locus coeruleus or the periaqueductal gray matter. Physical dependence was induced by chronic peripheral administration of morphine (from 7 to 30 mg/kg) and withdrawal syndrome was precipitated by injection of naloxone (2 micrograms) into the lateral ventricle. The administration of the serine/threonine kinase inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, H7 (1, 3, 10, and 30 nmol per side) into the locus coeruleus induced a strong attenuation of morphine withdrawal behavior. Signs related to the motor component of abstinence, such as jumping, rearing, and hyperactivity, were the most severely reduced. However, this effect was not dose-dependent, and the response was almost the same with all the doses used. A similar attenuation was observed after the injection of H7 (1, 3, and 10 nmol per side) into the periaqueductal gray matter, but in this case motor signs were less strongly reduced and a larger number of signs were modified, mainly when using the highest dose. The administration of the tyrosine kinase inhibitor 2-hydroxy-5-[N(2,5-dihydroxyphenyl)methyl]amino]-benzoic acid 3-phenylpropyl ester, KB23 (0.3, 1, and 3 nmol per side) into the locus coeruleus or the periaqueductal gray matter had no effect on the withdrawal syndrome behavior, except on teeth chattering. These results suggest that in the locus coeruleus and in the periaqueductal gray matter, serine/threonine kinases are implicated in the behavioral expression of morphine abstinence. In these brain structures, tyrosine kinases appear not to be involved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8751087     DOI: 10.1007/bf00169392

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

1.  Inhibition of protein tyrosine kinase activity by herbimycin A prevents anti-mu but not LPS-mediated cell cycle progression and differentiation of splenic B lymphocytes.

Authors:  X R Yao; D W Scott
Journal:  Cell Immunol       Date:  1993-07       Impact factor: 4.868

2.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

3.  Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration.

Authors:  I Marshall; M Weinstock
Journal:  Nature       Date:  1971-11-26       Impact factor: 49.962

4.  Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal.

Authors:  G F Koob; T L Wall; F E Bloom
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.

Authors:  R S Duman; J F Tallman; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

6.  An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation.

Authors:  R C Malenka; J A Kauer; D J Perkel; M D Mauk; P T Kelly; R A Nicoll; M N Waxham
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

7.  Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.

Authors:  S Gucker; J M Bidlack
Journal:  Mol Pharmacol       Date:  1992-10       Impact factor: 4.436

8.  Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases.

Authors:  J S Nixon; S E Wilkinson; P D Davis; A D Sedgwick; J Wadsworth; D Westmacott
Journal:  Agents Actions       Date:  1991-03

Review 9.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

10.  Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel.

Authors:  Y Chen; L Yu
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  20 in total

1.  Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil.

Authors:  M A Hurlé; I Goirigolzarri; E M Valdizán
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.

Authors:  S B Lane-Ladd; J Pineda; V A Boundy; T Pfeuffer; J Krupinski; G K Aghajanian; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies.

Authors:  Venetia Zachariou; Rongjian Liu; Quincey LaPlant; Guanghua Xiao; William Renthal; Guy C Chan; Daniel R Storm; George Aghajanian; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2008-01-28       Impact factor: 13.382

4.  Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray.

Authors:  L J Punch; D W Self; E J Nestler; J R Taylor
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 5.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

6.  Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.

Authors:  M Mas-Nieto; B Pommier; E T Tzavara; A Caneparo; S Da Nascimento; G Le Fur; B P Roques; F Noble
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment.

Authors:  E J Van Bockstaele; J Peoples; A S Menko; K McHugh; G Drolet
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

8.  Local opioid withdrawal in rat single periaqueductal gray neurons in vitro.

Authors:  B Chieng; M D Christie
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

9.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

Review 10.  Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".

Authors:  Eric J Nestler
Journal:  Brain Res       Date:  2015-12-29       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.